We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Baxalta Loses Motion for Patent Infringement Retrial Against Bayer
Baxalta Loses Motion for Patent Infringement Retrial Against Bayer
A federal court in Delaware has denied Baxalta’s request for a new trial in a suit brought by Bayer over patent infringement by Baxalta’s hemophilia A drug Adynovate.